Historical Stock Price
NVGN historical stock prices picture
NVGN (NVGN) has the following price history information. Looking back at NVGN historical stock prices for the last five trading days, on November 16, 2017, NVGN opened at $3.08, traded as high as $3.20 and as low as $3.08, and closed at $3.20. Trading volume was a total of 8.40K shares. On November 17, 2017, NVGN opened at $3.25, traded as high as $3.36 and as low as $3.13, and closed at $3.13. Trading volume was a total of 12.80K shares. On November 20, 2017, NVGN opened at $3.15, traded as high as $3.29 and as low as $2.96, and closed at $2.96. Trading volume was a total of 4.10K shares. On November 21, 2017, NVGN opened at $2.95, traded as high as $3.06 and as low as $2.86, and closed at $2.99. Trading volume was a total of 5.50K shares. On November 22, 2017, NVGN opened at $3.16, traded as high as $3.20 and as low as $3.00, and closed at $3.17. Trading volume was a total of 3.60K shares.

NVGN Historical Stock Prices By Date:

NVGN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVGN shares, starting with a $10,000 purchase of NVGN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 11/22/2017
Start price/share: $4.15
End price/share: $3.17
Dividends collected/share: $0.00
Total return: -23.61%
Average Annual Total Return: -7.12%
Starting investment: $10,000.00
Ending investment: $7,638.81
Years: 3.65
Date Open High Low Close Volume
11/16/2017 $3.08 $3.20 $3.08 $3.20 8.40K
11/17/2017 $3.25 $3.36 $3.13 $3.13 12.80K
11/20/2017 $3.15 $3.29 $2.96 $2.96 4.10K
11/21/2017 $2.95 $3.06 $2.86 $2.99 5.50K
11/22/2017 $3.16 $3.20 $3.00 $3.17 3.60K
Novogen is a global oncology biotechnology company, focused on developing cancer treatments. Co. has two main drug technology platforms: super-benzopyran and anti-tropomyosins (ATM). Within those platforms, Co. has three drug candidates under development: Cantrixil (TRX-E-002-1), for women with later-stage ovarian cancer; Anisina (ATM-3507), which is designed to enhance chemotherapy agents such as taxanes and vinca alkaloids, which are used across a range of cancer treatments including lung, prostate, colon, gastric, prostrate, pancreatic and breast cancer, as well as many childhood cancers; and Trilexium (TRX-E-009-1), for treatment of renal cancer and several childhood cancers.
Date Close
11/16/2017$3.20
11/17/2017$3.13
11/20/2017$2.96
11/21/2017$2.99
11/22/2017$3.17
NVGN is categorized under the Healthcare sector; below are some other companies in the same sector:

NVIV Historical Stock Prices
NVLS Historical Stock Prices
NVO Historical Stock Prices
NVRO Historical Stock Prices
NVTA Historical Stock Prices
NVTR Historical Stock Prices
NVUS Historical Stock Prices
NWBO Historical Stock Prices
NWBOW Historical Stock Prices
NXTM Historical Stock Prices

Email EnvelopeFree NVGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


NVGN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.